Integra LifeSciences Launches $600 Million Senior Secured Term Loan B

08:21 AM EDT, 10/02/2026 (MT Newswires) -- Integra LifeSciences (IART) said Friday that it has launched a $600 million seven-year senior secured term loan B as part of a broader refinancing transaction. The medical technology company said it plans to use the net proceeds from the loan, along with other sources of financing, to refinance some of its existing indebtedness and pay associated fees and expenses. The proposed senior secured term loan B is expected to be completed together with a broader refinancing of the company's existing capital structure, Integra said.